Tagged: licensing
14 results
Mighty Jaxx
Mighty Jaxx is a Singapore-based, technology-driven brand platform that designs, manufactures and distributes limited-edition art toys and 'phygital' collectibles. Founded by Jackson Aw in 2012, it pairs licensed pop-culture partnerships (Netflix, Disney, Hasbro, DC Comics, Formula 1, Toei Animation) with more than 120 artists, and embeds NFC chips into products to enable blockchain-based authentication and a digital fan journey. The company ships to collectors in 90+ countries and operates a family of brands spanning collectibles, retail (PLAYe), experiences and Web3.
Tradespace
Tradespace is a San Francisco company building an end-to-end, AI-powered platform for managing intellectual property. It covers the full patent lifecycle - invention capture, AI-assisted drafting, prosecution, portfolio management and commercialization - so in-house IP teams can run a scalable function without paying traditional law-firm billable-hour rates. The platform manages over 440,000 patents for 80+ organizations, including Fortune 500 companies and roughly 75% of top US research universities.
Scott Sackett
Scott Sackett is Chief Advisor to the CEO at Artifex Software, the San Francisco company behind Ghostscript, MuPDF, and PyMuPDF. He has been at Artifex since January 1998, spending more than two decades running sales and licensing before shifting into an advisory seat. Before software, he was a working musician in the Bay Area and then an airline pilot for Braniff. He lives in Krum, Texas, and sits on the Denton Record-Chronicle editorial board.
Shawn Cantor
Shawn Cantor is co-founder and Chief Operating Officer of Certemy, a Series B compliance and credentialing SaaS company he started in 2017 with Zorik Gordon. Before Certemy, he served as COO of WorkWave (acquired by IFS in 2018), spent eight years at ReachLocal building its North American sales channel to more than 600 employees and $200M in revenue, and founded JAC Media, a digital marketing agency acquired by ReachLocal in 2005. His career is a sequence of building operations engines for outbound sales and services businesses.
Ramon Salsas Escat
Ramon Salsas Escat is the Chief Business Officer of GEMMA Biotherapeutics (GemmaBio), the Philadelphia gene-therapy company spun out of Jim Wilson's lab to widen global access to AAV therapies for rare inherited diseases. A chemist by training who earned a PhD in computational and systems biology at MIT and an MBA at IESE, Salsas has led or co-led more than 20 transactions across AAV gene therapies, CNS disorders, oncology and manufacturing platforms, with cumulative deal value north of $4 billion in upfront payments and milestones. He helped build the business engine at Penn's Gene Therapy Program, served as SVP of Business Development at G2 Bio, and now runs business development, alliance management, legal and IP at GemmaBio, where he played a pivotal role in the company's founding and its $34 million seed round.
Ruvixx, Inc.
Ruvixx is a San Francisco-based SaaS company that helps licensing, brand protection and compliance teams turn scattered data into recoverable revenue. Its platform centralizes intellectual-property workflows - from lead detection to royalty reporting - pairing AI-driven analytics and OSINT with human expert teams. Trusted by enterprises like Dolby, Adobe, Trimble and Chaos Group, Ruvixx targets the trillion-dollar gap between what brands are owed and what they actually collect.
Michael Shih
Michael Shih is the Chief Executive Officer of NeoPhore Ltd, a London-based small molecule neoantigen immuno-oncology company developing first-in-class drugs that target the DNA mismatch repair (MMR) pathway to make cancers more visible to the immune system. An attorney by training with degrees in biology, he spent nearly two decades structuring biotech deals before sitting in the chief executive's chair, with senior business development and corporate development roles at Kite Pharma, Biogen, Sanofi, Epizyme, Forest Laboratories, Kastle Therapeutics and Eisai. He took the helm at NeoPhore in December 2024, right after the company closed an oversubscribed Series B round backed by Bristol Myers Squibb.
CertifyOS
CertifyOS is a New York-based healthcare technology company building the provider data infrastructure layer for health plans, health systems, and digital health companies. Its API-first platform automates credentialing, licensing, enrollment, and continuous network monitoring, unifying data from thousands of primary sources into a single, continuously updated source of truth. Founded by former Oscar Health operators, the NCQA-accredited CVO tracks 1,600+ data points per provider and manages 15+ million licenses, turning a notoriously slow, manual back-office process into real-time infrastructure.
GovWell
GovWell builds an AI-native software platform for state and local governments, replacing legacy permitting, licensing, inspections, planning and code enforcement systems with a single configurable, cloud-based product. Founded in 2023 and based in New York, the company says it cuts permit and license processing time by up to 95% and serves well over 100 municipalities and counties across more than 30 states. In May 2026 it raised a $25M Series A led by Insight Partners.
David Steinberg
David Steinberg is Chief Business Officer at Formation Bio, an AI-native pharmaceutical company in New York, where he runs in- and out-licensing and pipeline strategy. A serial biotech company builder, he co-founded PureTech Health and served as its Chief Innovation Officer, was a General Partner at Longwood Fund, and founded or led a string of NASDAQ-listed and venture-backed companies including Pyxis Oncology, Vor Biopharma, Vedanta Biosciences and Be Biopharma. He pairs a Cornell biology degree with a University of Chicago Booth MBA and a career that began in R&D and strategy consulting.
Marguerite Hutchinson
Marguerite Hutchinson, J.D., is the Chief Business Officer of STORM Therapeutics, a Cambridge, UK clinical-stage biotech advancing the first RNA methyltransferase inhibitor into clinical development. A Harvard graduate and lawyer by training, she has spent more than a decade turning early science into deals - building licensing partnerships with Roche, Merck, AstraZeneca, AbbVie and Cancer Research UK, founding and funding a UCSF spin-out, and steering a first-in-class cancer drug through to approval. She was named one of the Top 25 Women Leaders in Biotechnology.
Tim Bernstein
Tim Bernstein is the CEO of yet2, an open innovation and technology scouting firm founded in 1999 with backing from DuPont, Procter & Gamble, Honeywell and Siemens. He joined the company in 2001, rose from operator to chief executive, and now spends his days matching corporate R&D needs with technologies and partners pulled from a database of more than five million solution providers. A Yale economist with a Stanford MBA and a Harvard Kennedy School policy degree, he turned an academic thesis on university licensing into a career spent brokering deals others could not find.
BreezeBio
BreezeBio (formerly GenEdit) is a Brisbane, California-based biotechnology company that develops precision genetic medicines using its proprietary NanoGalaxy platform - a library of polymer nanoparticles capable of delivering genetic payloads like mRNA, siRNA, and CRISPR components to specific tissues without triggering immune responses. Unlike viral vectors that can only be dosed once and often provoke dangerous immune reactions, BreezeBio's non-viral approach allows repeat dosing, broad payload flexibility, and tissue selectivity across immune cells, heart, lung, and CNS. Founded in 2016 out of UC Berkeley by CEO Dr. Kunwoo Lee and CTO Dr. Hyo Min Park, the company rebranded from GenEdit in early 2026 following its $60M Series B, signaling a shift from delivery-platform licensor to full therapeutic developer with a lead program (BRZ-101) targeting Type 1 Diabetes.
Bill Campbell
Bill Campbell is the founder and CEO of Barefoot Media LLC, a global advisory firm specializing in digital strategy, content licensing, and fundraising for startups in the music, streaming, and entertainment tech space. With over 30 years of experience, he previously served as Senior Vice President of Global Digital Business at both Universal Music Group and Sony Music Entertainment, where he structured landmark deals with Spotify, Apple Music, Google, and Amazon. His client roster includes TikTok/Bytedance, SoundCloud, Square, and United Masters, making him one of the most influential behind-the-scenes operators in digital entertainment.